About Medesis Pharma S.A.

Company Description

Medesis Pharma is a clinical-stage Pharmaceutical Biotechnology company developing innovative technology (AONYS®) for the delivery of therapeutic molecules to treat diseases with no current efficacious treatment.

Legal structure :

Montpellier (France) Headquarters
Montreal (Canada) 100% subsidiary. Medesis Pharma Inc. is a subsidiary for collaborations with McGill University and the University of Montreal.

Year founded

2003

Served area

Worldwide

Headquarters

L'Orée des Mas Avenue du Golf, 34670 Baillargues, Montpellier – France

Shareholder information

Shares outstanding

4,365,344

IPO

Feb. 12, 2021

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.